Stay updated with breaking news from Mark Erlander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinancialNewsMedia.com News Commentary Palm Beach, Fla., Oct. 12, 2022 /PRNewswire/ -- The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth
Next trial in RAS-mutated mCRC (ONSEMBLE) is a randomized Phase 2 trial to demonstrate onvansertib's contribution to SoC and position for a possible...
Initial preclinical data in ovarian cancer presented at AACR showed treatment with onvansertib plus olaparib leading to a statistically significant survival...
Bolstered by the success of KRAS G12C inhibitors in lung cancer, smaller firms are developing drugs for a range of other KRAS-mutated cancers and trying to anticipate resistance.
Reported new Phase 1b/2 data from lead KRAS-mutated metastatic colorectal cancer (mCRC) clinical program showing objective response rate and median...